Navigation Links
Amicus Therapeutics Announces Second Quarter 2008 Financial Results
Date:8/7/2008

ly, Amicus announced that it had successfully completed an End of Phase 2 meeting for Amigal with the U.S. Food and Drug Administration (FDA). The FDA indicated that the data from the completed Phase 2 clinical studies of Amigal support the start of Phase 3 development and agreed that Amigal meets the criteria to be considered for accelerated approval. The Agency further indicated that it is not opposed to the use of a surrogate primary endpoint, pending further discussion and final agreement on the Phase 3 trial design.

Amicus, along with its partner Shire Human Genetic Therapies, Inc. ("Shire"), is engaged in ongoing discussions with FDA and the European Medicines Agency (EMEA) regarding plans for a global Phase 3 clinical development program for Amigal. In line with previous guidance, Amicus expects to complete these interactions in the second half of 2008, and subject to the outcome of the discussions, the Company plans to initiate Phase 3 development of Amigal in the first half of 2009.

In parallel with the regulatory process, 23 of the original 26 patients will continue to be treated with Amigal in a voluntary Phase 2 extension study to monitor long term safety and efficacy and to evaluate additional doses and dose regimens. Data from this extension study are expected to be available by Q1 2009. In addition, Amicus expects to conduct clinical pharmacology studies to support the Phase 3 program.

Gaucher Disease:

Plicera(TM) (isofagomine tartrate) is an investigational, oral therapeutic in Phase 2 development for the treatment of Gaucher disease. As previously disclosed, Amicus amended the protocol for the ongoing 6-month Phase 2 clinical trial of Plicera in patients naive to ERT to include modified doses and dose regimens. Amicus expects the results of this study to be available in 2009.

The Company has modified its development plan for Plicera to include a study of the pharmacokinetics of Plicera in Gaucher patients. In addit
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
2. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
3. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
6. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
7. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
8. Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
9. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
10. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
11. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... LA VERNE, Calif. , Oct. 22, 2014 ... emergency readiness products, has developed APLS ® ... bag that minimizes the spread of bacteria and ... APLS Body Guard Bio features a ... and finished edges that create a leak-proof inner ...
(Date:10/22/2014)... 22, 2014  CryoLife, Inc. (NYSE: CRY ... focused on cardiac and vascular surgery, announced today that ... Executive Officer, has been elected to the Company,s Board ... Steven G. Anderson , Executive Chairman of CryoLife, stated, "Since ... be an excellent leader who is well positioned to ...
(Date:10/22/2014)... , Oct. 21, 2014   BioNano Genomics ... latest genomics research centers to purchase an ... the National Cancer Institute (NCI), NIH Intramural Sequencing ... Before Irys, obtaining a comprehensive view of a ... sequencing (NGS) does not deliver the scalability or ...
Breaking Medicine Technology:New, State-Of-The-Art Body Bag Minimizes The Spread Of Bacteria And Virus 2Pat Mackin Joins CryoLife Board of Directors 2Pat Mackin Joins CryoLife Board of Directors 3BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
... of Vermillion, Inc. (NASDAQ: VRML ), a leading ... successor to Gail S. Page, president and CEO. The board ... the search by September 2012. James S. Burns, ... led the divestiture of the company,s original research tools business, ...
...  InfuSystem Holdings, Inc. (NYSE MKT:  INFU), the leading national ... healthcare industry, today announced that it will release results ... 2012 following the market close.  The ... May 22, 2012 at 9:00 a.m. Eastern Time.  To ...
Cached Medicine Technology:Vermillion Announces CEO Succession Plan 2Vermillion Announces CEO Succession Plan 3Vermillion Announces CEO Succession Plan 4
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... may lead to increased blood pressure, according to a new ... in blood pressure for young adult women or for teenagers, ... drank lightly or moderately, their risk of high blood pressure ... parallels studies in older adult men and women," said lead ...
(Date:10/22/2014)... News) -- Measures taken by Firestone officials at the ... have limited the spread of the disease there and ... Natural Rubber Co. provides health services to about 80,000 ... populated communities. Between Aug. 1 and Sept. 23, ... those 80,000 people. That incidence rate of 0.09 percent ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... cameraman who was diagnosed with Ebola while working for NBC ... and can leave the special isolation unit at Nebraska Medical Center ... weeks, the hospital said Tuesday. A blood test confirmed by ... Mukpo, 33, can head home to Providence, R.I., NBC News ...
(Date:10/20/2014)... With a mere 19 days to November ... brief fundraising stop at the  Law Offices of ... a debate last night with his opponent Gov. Rick ... first seven minutes because Crist had an electric fan ... in one word: "weird." , Before touching on his ...
(Date:10/20/2014)... The Advocator Group, LLC is ... Foundation for Suicide Prevention’s (AFSP) Out of the Darkness ... organization that hosts hundreds of community walks throughout the ... used to help understand and prevent suicide through not ... well. , The Advocator Group shares this passion ...
Breaking Medicine News(10 mins):Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3
... Mass. and SYDNEY, Australia, April 18 ,HeartWare Limited ... to an,expanded, upgraded manufacturing facility in Miami Lakes, ... nearly twice the size of HeartWare,s,current facility, will ... is,expected to meet all of the Company,s operational ...
... 17, 2008) - The Life Sciences Discovery Fund ... to 5 Washington State-based life sciences organizations and ... the areas of medical genetics, autoimmunity, cancer clinical ... (See Backgrounder Information). , The grant awardees are: ...
... 18 Avalon Health Care, Inc. today,announced that the ... has,become the first skilled nursing facility in the state ... the American Association,for Respiratory Care (AARC)., "Earning the ... This achievement reflects Avalon,s overall goal of providing a,higher ...
... Four-legged heroes -- cats, too -- are maintaining the veterinary ... most of America,s blood donors, JJ and Logan are unaware ... saved. , But over a three-year period, the two healthy ... numerous canine patients survive surgeries and illnesses to play "fetch" ...
... house aide,Robert Weiner, and Dr. Patricia Berg, director of ... many scientists believe that "the,cost of the Iraq war ... for,cancer research, and private organizations, though critical, are a ... are being,lost due to "the high funding bar.", ...
... 17 When Wiley Coyote goes,hungry in cartoon ... in the,real world, Roadrunner Food Bank wins when ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080417/LATH545-b ), In that ... Mexico,s Roadrunner Food Bank to highlight the tragedy ...
Cached Medicine News:Health News:HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility 2Health News:HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility 3Health News:Life Sciences Fund grants awards to launch health research 2Health News:Life Sciences Fund grants awards to launch health research 3Health News:Life Sciences Fund grants awards to launch health research 4Health News:Life Sciences Fund grants awards to launch health research 5Health News:Woodland Park Care Center Earns Quality Respiratory Care Recognition 2Health News:Donor Dogs Give the Gift of Life 2Health News:Donor Dogs Give the Gift of Life 3Health News:Donor Dogs Give the Gift of Life 4Health News:Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers 2Health News:BEEP BEEP!! Strategic Communications Firm DW Turner Thwarts Hunger in Partnership With Roadrunner Food Bank 2
... Shandon Cryotome FE and FSE are a ... Electron. The microtome is outside of the ... as well as faster temperature adjustment. Simple, ... Complete temperature controls on the main touch-screen ...
A standard, durable and reliable indirect....
Designed to retain the desired curve during oral intubation....
Facilitates intubation of tracheal tubes....
Medicine Products: